Yu Liu and Waleed Mussa are stepping back from the Australian AI healthcare company just weeks after it secured a $1.26 billion valuation.
Yu Liu and Waleed Mussa are stepping back from the Australian AI healthcare company just weeks after it secured a $1.26 billion valuation.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.